Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells

PLGA-based nanoparticles: An overview of biomedical applications

Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Breton, A. L., & Véronique Préat, A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,884 · see citing works

Trypan Blue Exclusion Test of Cell Viability

Strober, W. (2015) · Current Protocols in Immunology · doi:10.1002/0471142735.ima03bs111 · Cited by 2,623 · see citing works

Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size

Cabral, H., Matsumoto, Y., Mizuno, K., Chen, Q., Murakami, M., Kimura, M., Terada, Y., Kano, M. R., Miyazono, K., Uesaka, M., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.166 · Cited by 2,429 · see citing works

Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applications

Wu, W., Wu, Z., Yu, T., Jiang, C., & Kim, W.-S. (2015) · Science and Technology of Advanced Materials · doi:10.1088/1468-6996/16/2/023501 · Cited by 1,574 · see citing works

Trypan Blue Exclusion Test of Cell Viability

Strober, W. (1997) · Current Protocols in Immunology · doi:10.1002/0471142735.ima03bs21 · Cited by 1,349 · see citing works

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group

Hiddemann, W. (2005) · Blood · doi:10.1182/blood-2005-01-0016 · Cited by 1,317 · see citing works

Iron Oxide Nanoparticles for Sustained Delivery of Anticancer Agents

Jain, T. K., Morales, M. A., Sahoo, S. K., Leslie‐Pelecky, D. L., & Labhasetwar, V. D. (2005) · Molecular Pharmaceutics · doi:10.1021/mp0500014 · Cited by 904 · see citing works

Structure and functions of nucleolin

Ginisty, H., Sicard, H., Roger, B., & Bouvet, P. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.6.761 · Cited by 776 · see citing works

Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation

Danhier, F., Lecouturier, N., Vroman, B., Jérôme, C., Marchand‐Brynaert, J., Féron, O., & Véronique Préat, A. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.086 · Cited by 617 · see citing works

Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery

Guo, J., Gao, X., Su, L., Xia, H., Gu, G., Pang, Z., Jiang, X., Yao, L., Chen, J., & Chen, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.004 · Cited by 567 · see citing works

Molecular dissection of nucleolin's role in growth and cell proliferation: new insights

Srivastava, M., & Pollard, H. B. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.1911 · Cited by 495 · see citing works

Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment

Cui, Y., Xu, Q., Chow, P. K. H., Wang, D., & Wang, C. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.075 · Cited by 377 · see citing works

Stealth Properties to Improve Therapeutic Efficacy of Drug Nanocarriers

Salmaso, S., & Caliceti, P. (2013) · Journal of Drug Delivery · doi:10.1155/2013/374252 · Cited by 340 · see citing works

Nanomaterials for Photo-Based Diagnostic and Therapeutic Applications

Menon, J. U., Jadeja, P., Tambe, P., Vu, K., Yuan, B., & Nguyen, K. T. (2013) · Theranostics · doi:10.7150/thno.5327 · Cited by 284 · see citing works

Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles

Gao, H., Qian, J., Cao, S., Yang, Z. H., Pang, Z., Pan, S., Fan, L., Xi, Z., Jiang, X., & Zhang, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.058 · Cited by 280 · see citing works

Concepts and practices used to develop functional PLGA-based nanoparticulate systems

Sah, H., Desu, H. R., Sah, Wood, & Thoma (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s40579 · Cited by 218 · see citing works

Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging

Schleich, N., Sibret, P., Danhier, P., Učakar, B., Laurent, S., Müller, R. N., Jérôme, C., Gallez, B., Véronique Préat, A., & Danhier, F. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.042 · Cited by 215 · see citing works

Doxorubicin loaded superparamagnetic PLGA-iron oxide multifunctional microbubbles for dual-mode US/MR imaging and therapy of metastasis in lymph nodes

Niu, C., Wang, Z., Lu, G., Krupka, T. M., Sun, Y., You, Y.-F., Song, W., Ran, H., Li, P., & Zheng, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.003 · Cited by 192 · see citing works

Magnetic Nanoparticles for Cancer Diagnosis and Therapy

Yigit, M. V., Moore, A. V., & Medarova, Z. O. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0679-7 · Cited by 190 · see citing works

Mechanistic studies of anticancer aptamer AS1411 reveal a novel role for nucleolin in regulating Rac1 activation

Reyes‐Reyes, E. M., Šalipur, F. R., Mitra, S., Forsthoefel, M. K., & Bates, P. J. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.03.012 · Cited by 180 · see citing works

Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles

Hu, F., Neoh, K. G., & Kang, E. T. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.07.014 · Cited by 165 · see citing works

Suppression of Tumor Growth and Angiogenesis by a Specific Antagonist of the Cell-Surface Expressed Nucleolin

Destouches, D., Khoury, D. E., Hamma‐Kourbali, Y., Krust, B., Albanese, P., Katsoris, P., Guichard, G., Briand, J. P., Courty, J., & Hovanessian, A. G. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002518 · Cited by 153 · see citing works

Whole-cell SELEX aptamer-functionalised poly(ethyleneglycol)-poly(ε-caprolactone) nanoparticles for enhanced targeted glioblastoma therapy

Gao, H., Qian, J., Yang, Z. H., Pang, Z., Xi, Z., Cao, S., Wang, Y., Pan, S., Zhang, S., Wang, W., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.05.020 · Cited by 150 · see citing works

In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer

Alibolandi, M., Ramezani, M., Abnous, K., Sadeghi, F., Atyabi, F., Asouri, M., Ahmadi, A. A., & Hadizadeh, F. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.04.026 · Cited by 147 · see citing works

Smart ligand: Aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy

Li, X., Zhao, Q., & Qiu, L. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.06.006 · Cited by 144 · see citing works

Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas

Blay, J., Leahy, M. G., Nguyen, B. B., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.01.012 · Cited by 120 · see citing works

AS1411-conjugated gold nanospheres and their potential for breast cancer therapy

Malik, M. T., O’Toole, M. G., Casson, L. K., Thomas, S. D., Bardi, G. T., Reyes‐Reyes, E. M., Ng, C. K., Kang, K. A., & Bates, P. J. (2015) · Oncotarget · doi:10.18632/oncotarget.4207 · Cited by 116 · see citing works

Cancer targeted therapeutics: From molecules to drug delivery vehicles

Liu, D., & Auguste, D. T. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.041 · Cited by 112 · see citing works

Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood–brain barrier

Chen, Y., Hsieh, W.-Y., Lee, W., & Zeng, D.-T. (2011) · Journal of Biomaterials Applications · doi:10.1177/0885328211429495 · Cited by 105 · see citing works

Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas

Amin, M., Badiee, A., & Jaafari, M. R. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.10.018 · Cited by 101 · see citing works

Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticles

Chittasupho, C., Lirdprapamongkol, K., Kewsuwan, P., & Sarisuta, N. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.06.020 · Cited by 97 · see citing works

Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma

Ling, Y., Wei, K., Zou, F., & Zhong, S. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.03.047 · Cited by 93 · see citing works

Combined modality doxorubicin-based chemotherapy and chitosan-mediated p53 gene therapy using double-walled microspheres for treatment of human hepatocellular carcinoma

Xu, Q., Leong, J., Chua, Q. Y., Chi, Y. T., Chow, P. K. H., Pack, D. W., & Wang, C. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.044 · Cited by 89 · see citing works

Preparation and evaluation of polyethylenimine-functionalized carbon nanotubes tagged with 5TR1 aptamer for targeted delivery of Bcl-xL shRNA into breast cancer cells

Taghavi, S., HashemNia, A., Mosaffa, F., et al. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.12.021 · Cited by 85 · see citing works

Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region

Amin, M., Mansourian, M., Koning, G. A., Badiee, A., Jaafari, M. R., & ten Hagen, T. L. M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.039 · Cited by 83 · see citing works

Progress in Aptamer-Mediated Drug Delivery Vehicles for Cancer Targeting and Its Implications in Addressing Chemotherapeutic Challenges

Zhu, J., Huang, H., Dong, S., Ge, L., & Zhang, Y. (2014) · Theranostics · doi:10.7150/thno.9663 · Cited by 81 · see citing works

Study and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays compared with normal assays

Gao, H., Yang, Z. H., Zhang, S., Pang, Z., Liu, Q., & Jiang, X. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.11.003 · Cited by 79 · see citing works

Aptamer conjugated paclitaxel and magnetic fluid loaded fluorescently tagged PLGA nanoparticles for targeted cancer therapy

Aravind, A., Nair, R., Raveendran, S., Veeranarayanan, S., Nagaoka, Y., Fukuda, T., Hasumura, T., Morimoto, H., Yoshida, Y., Maekawa, T., et al. (2013) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2013.05.036 · Cited by 49 · see citing works

Doxorubicin-mediated radiosensitivity in multicellular spheroids from a lung cancer cell line is enhanced by composite micelle encapsulation

Wei, Q., Xu, W., Han, M. Y., et al. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30445 · Cited by 45 · see citing works

A multiple emulsion method for loading 5-fluorouracil into a magnetite-loaded nanocapsule: a physicochemical investigation

Ashjari, M., Khoee, S., & Mahdavian, A. R. (2012) · Polymer International · doi:10.1002/pi.4154 · Cited by 43 · see citing works

Investigation of Hexadecylphosphocholine (miltefosine) usage in Pegylated liposomal doxorubicin as a synergistic ingredient: In vitro and in vivo evaluation in mice bearing C26 colon carcinoma and B16F0 melanoma

Teymouri, M., Farzaneh, H., Badiee, A., et al. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.08.011 · Cited by 27 · see citing works

Nucleolin mediates the antiangiogenesis effect of the pseudopeptide N6L

Birmpas, C., Briand, J. P., Courty, J., et al. (2012) · BMC Cell Biology · doi:10.1186/1471-2121-13-32 · Cited by 27 · see citing works

PEG-PLGA Nanoparticles Entrapping Doxorubicin Reduced Doxorubicin-Induced Cardiotoxicity in Rats

Mao, J. N., Li, A. J., Zhao, L., et al. (2014) · Advanced materials research · doi:10.4028/www.scientific.net/amr.912-914.263 · Cited by 14 · see citing works

Aptamer-guided nanomedicines for anticancer drug delivery

Alshaer, W., Hillaireau, H., & Fattal, E. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.09.011 · Cited by 187 · see citing works

Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment

Liang, X., Wang, Y., Shi, H., Dong, M., Han, H., & Li, Q. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s304526 · Cited by 41 · see citing works

Nucleolin Overexpression Confers Increased Sensitivity to the Anti-Nucleolin Aptamer, AS1411

Sharma, V. R., Thomas, S. D., Miller, D. M., et al. (2018) · Cancer Investigation · doi:10.1080/07357907.2018.1527930 · Cited by 42 · see citing works

Chemotherapeutic, Toxin, and Therapeutic Protein Delivery via Nucleolin Aptamer-functionalized Nanoplatforms for Targeted Cancer Therapy

Kozani, P. S., Kozani, P. S., & Rahbarizadeh, F. (2021) · Trends in Medical Sciences · doi:10.5812/tms.113773 · Cited by 2 · see citing works

Surface Expressed Nucleolin Is Constantly Induced in Tumor Cells to Mediate Calcium-Dependent Ligand Internalization

Hovanessian, A. G., Soundaramourty, C., Khoury, D. E., Nondier, I., Svab, J., & Krust, B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015787 · Cited by 219 · see citing works

Roles of nucleolin

Chen, Z., & Xu, X. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.12.15972 · Cited by 102 · see citing works

295 NUCLEOLIN, A NOVEL TARGET FOR APTAMER-BASED ANTICANCER THERAPY

Miller, D. M., Bates, P. J., Trent, J. O., et al. (2005) · Journal of Investigative Medicine · doi:10.2310/6650.2005.00006.294